Search

everythinglearnresearchcommunity

for

Search:↓

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

The review found that basal cell carcinomas on the scalp are not more aggressive than those in other locations.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Nevoid basal cell carcinomas start in the skin's top layer and hair follicles.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Looking at tissue characteristics isn't reliable for telling apart basal cell carcinoma from certain benign skin tumors.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Complex basal cell carcinomas need personalized treatment due to unique genetic mutations.

The treatment was ineffective in humans.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

Basal cell carcinoma may start from parts of tiny hair follicles.

Trichoblastic fibroma and basal cell carcinoma are similar but different from trichoepithelioma.

Raman micro-spectroscopy can help distinguish basal cell carcinoma from hair follicles in skin tissue.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

High-frequency ultrasound effectively measures basal cell carcinoma depth.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Heat shock proteins help basal cell carcinoma grow by responding to inflammation signals.

Different tumor cells in one basal cell carcinoma can cause mixed treatment responses, suggesting personalized treatment is needed.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.